Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (991-1000 of 1,023) with videos related to

Pageof 103
Sort By:
Journal of the American College of Cardiology|March 23, 2019
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT TrialOtavio Berwanger, Renato D Lopes, Diogo D F Moia, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
European Journal of Heart Failure|April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trialJawad H Butt, Brian L Claggett, Zi M Miao, et al.
The New England Journal of Medicine|November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial InfarctionMarc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
JAMA Cardiology|March 12, 2018
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical TrialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
Journal of the American Medical Informatics Association : JAMIA|September 13, 2016
Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitusSusan E Spratt, Katherine Pereira, Bradi B Granger, et al.
Circulation|September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS TrialStephan Windecker, Renato D Lopes, Tyler Massaro, et al.
Science (New York, N.Y.)|May 5, 2007
A common variant on chromosome 9p21 affects the risk of myocardial infarctionAnna Helgadottir, Gudmar Thorleifsson, Andrei Manolescu, et al.
Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.
Pageof 103

Showing results (991-1000 of 1,023) with videos related to

Sort By:
Pageof 103
Journal of the American College of Cardiology|March 23, 2019
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT TrialOtavio Berwanger, Renato D Lopes, Diogo D F Moia, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
European Journal of Heart Failure|April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trialJawad H Butt, Brian L Claggett, Zi M Miao, et al.
The New England Journal of Medicine|November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial InfarctionMarc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
JAMA Cardiology|March 12, 2018
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical TrialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
Journal of the American Medical Informatics Association : JAMIA|September 13, 2016
Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitusSusan E Spratt, Katherine Pereira, Bradi B Granger, et al.
Circulation|September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS TrialStephan Windecker, Renato D Lopes, Tyler Massaro, et al.
Science (New York, N.Y.)|May 5, 2007
A common variant on chromosome 9p21 affects the risk of myocardial infarctionAnna Helgadottir, Gudmar Thorleifsson, Andrei Manolescu, et al.
Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.
Pageof 103